{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"20"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"The percentage of people in a study or treatment group who are alive for a certain period of time after they were diagnosed with or treated for a disease, such as cancer. Also called survival rate.\n\nOverall survival will be defined as time from date of enrollment to date of death or censored at the date of last documented contact for patients still alive.","groups":[{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\\^8 CD3+ T-cells/kg","id":"OG000","title":"DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg"},{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\\^8 CD3+ T-cells/kg","id":"OG001","title":"DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"1 Year","title":"Number of Patients Alive","type":"PRIMARY","unitOfMeasure":"Participants"}